FoodMar 4, 2026
SB FOOD Yoyo Gummy Grape Plus Flavor, 2.8 Oz recall — FDA H-0529-2026
The products contain an unallowed color Carmoisine (E122) - Acid Red 14.
Class IIFDA: OngoingSB FOOD LLC
March 2026 recalls — page 8
These records include useful source details for the selected month.
FoodMar 4, 2026
Navitas, LLC NAVITAS ORGANICS ORGANIC CHIA SEEDS NET WT 8 OZ recall — FDA H-0533-2026
Potential contamination with Salmonella.
Class IFDA: OngoingNavitas, LLC.
FoodMar 4, 2026
TENGEN USA TRADING YO!MAN LETTUCE recall — FDA H-0526-2026
Product contains undeclared cyclamates.
Class IIIFDA: TerminatedTENGEN USA TRADING CORP
FoodMar 4, 2026
TENGEN USA TRADING YO!MAN CUCUMBER recall — FDA H-0525-2026
Product contains undeclared cyclamates.
Class IIIFDA: TerminatedTENGEN USA TRADING CORP
FoodMar 4, 2026
Valley Springs 100% Natural Bottled Water recall — FDA H-0535-2026
Water was bottled under insanitary conditions.
Class IIFDA: OngoingValley Springs Artesian Gold, LLC
DrugMar 4, 2026
C20H10NA2O5 FLUORESCEIN SODIUM OPHTHALMIC STRIPS CHNaO Fluorescein Sodium Ophthalmic Strips recall — FDA D-0350-2026
Lack of Assurance of Sterility: Products have not been manufactured in conformance with current good manufacturing practices.
Class IIFDA: OngoingWizcure Pharmaa Private Limited
DrugMar 4, 2026
Agebox iKids-Growth (Day Formula) capsules, 60-count bottles, Manufactured Exclusively For recall — FDA D-0344-2026
Marketed Without an Approved NDA/ANDA: presence of undeclared ibutamoren
Class IIFDA: OngoingAgebox
DrugMar 4, 2026
Vista Meibo Tears Propylene Glycol 0.6% w/v Eye Drops Advanced Dry Eye Relief Revitalizing recall — FDA D-0348-2026
Lack of Assurance of Sterility: Products have not been manufactured in conformance with current good manufacturing practices.
Class IIFDA: OngoingWizcure Pharmaa Private Limited
DrugMar 4, 2026
Agebox iKids-Growth (Night Formula), 60-count bottles, Manufactured Exclusively For: AGEBOX recall — FDA D-0345-2026
Marketed Without an Approved NDA/ANDA: presence of undeclared ibutamoren
Class IIFDA: OngoingAgebox
DrugMar 4, 2026
Vista Gonio Eye Lubricant, Hypromellose Ophthalmic Solution USP recall — FDA D-0349-2026
Lack of Assurance of Sterility: Products have not been manufactured in conformance with current good manufacturing practices.
Class IIFDA: OngoingWizcure Pharmaa Private Limited
DrugMar 4, 2026
ADBRY recall — FDA D-0339-2026
Lack of Assurance of Sterility: due to the presence of particulate matter in one unit from the lot, which lab tests have identified as wool fiber.
Class IIFDA: OngoingLEO PHARMA INC
DrugMar 4, 2026
Vista Gel Hypromellose USP 0.3% w/v, Eye Drops Dry Eye Relief Lubricating Gel, 10 ml. recall — FDA D-0347-2026
Lack of Assurance of Sterility: Products have not been manufactured in conformance with current good manufacturing practices.
Class IIFDA: OngoingWizcure Pharmaa Private Limited
DrugMar 4, 2026
Amantadine HCl, Capsules, UPS, 100 mg, 50 Capsules (5 x 10) unit dose recall — FDA D-0341-2026
Failed Dissolution Specifications: This recall has been initiated due to an Out of Specification finding in dissolution.
Class IIFDA: OngoingAvKARE
DrugMar 4, 2026
Eptifibatide Injection, 75 mg/100 mL vial for weight-adjusted bolus dosing, 1x100 mL recall — FDA D-0343-2026
Labeling: Not Elsewhere Classified. The carton for Eptifibatide Injection 75 mg/100 mL states 75 mg/100 mL vial for weight-adjusted bolus dosing. The approved statement is 75 mg/100 mL vial…
Class IIIFDA: OngoingSlate Run Pharmaceuticals
DrugMar 4, 2026
Wizcure Pharmaa Private Vista Tears Polyethylene Glycol 400 0.4% w/v, Propylene Glycol 0.3% recall — FDA D-0346-2026
Lack of Assurance of Sterility: Products have not been manufactured in conformance with current good manufacturing practices.
Class IIFDA: OngoingWizcure Pharmaa Private Limited
DrugMar 4, 2026
Wizcure Pharmaa Private Bio Glo Fluorescein Sodium Ophthalmic Strips USP, 300 diagnostic recall — FDA D-0351-2026
Lack of Assurance of Sterility: Products have not been manufactured in conformance with current good manufacturing practices.
Class IIFDA: OngoingWizcure Pharmaa Private Limited
DrugMar 4, 2026
Wizcure Pharmaa Private BioGlo Fluorescein Sodium Ophthalmic Strips USP, 100 diagnostic recall — FDA D-0352-2026
Lack of Assurance of Sterility: Products have not been manufactured in conformance with current good manufacturing practices.
Class IIFDA: OngoingWizcure Pharmaa Private Limited
VehicleMar 3, 2026
Ford back over prevention software recall — NHTSA campaign 26V124000
Ford Motor Company (Ford) is recalling certain 2021-2026 Ford Bronco and 2021-2024 Ford Edge vehicles. The Accessory Protocol Interface Module (APIM) may overheat and shutdown, which can…
back over prevention softwareFord Motor Company
VehicleMar 3, 2026
Ford motor recall — NHTSA campaign 26V117000
Ford Motor Company (Ford) is recalling certain 2020-2022 Explorer, Escape, Lincoln Aviator, and Lincoln Corsair vehicles. The windshield wiper motor may fail and prevent the windshield…
motorFord Motor Company
VehicleMar 3, 2026
Ford back over prevention software recall — NHTSA campaign 26V123000
Ford Motor Company (Ford) is recalling certain 2020-2022 Escape, Lincoln Corsair, 2020-2024 Lincoln Aviator, and Explorer vehicles. The image on the center display may flip or invert,…
back over prevention softwareFord Motor Company
VehicleMar 3, 2026
Ford gas recirculation valve (egr valve) recall — NHTSA campaign 26V122000
Ford Motor Company (Ford) is recalling certain 2025 Ranger, Lincoln Nautilus, Mustang, Maverick, Explorer, Escape, Lincoln Corsair, Bronco Sport, and Bronco vehicles. The exhaust gas…
gas recirculation valve (egr valve)Ford Motor Company
VehicleMar 3, 2026
Explorer headlights recall — NHTSA campaign 26V121000
Ford Motor Company (Ford) is recalling certain 2025-2026 Explorer vehicles. The Dynamic Bending Light (DBL) system software may cause the passenger-side headlight to turn in the wrong…
headlightsFord Motor Company
How to use this monthly recall archive
Use this page to compare the recalls reported during the month, then open an individual record for the exact reason, classification, company, remedy or distribution information available from the official source. Monthly counts are descriptive, not a safety rating.